IGF‑DES 2 mg Long‑Acting Growth Factor Peptide – Overview

This GMP‑certified peptide is the long‑acting analogue of insulin‑like growth factor‑des (IGF‑DES). The DES modification prolongs the half‑life to ~24 hours, making the IGF‑DES 2 mg Long‑Acting Growth Factor Peptide the preferred tool for anabolic‑research, muscle‑hypertrophy and cellular‑proliferation experiments. Purity is verified at ≥ 99 % (HPLC) and the product is endotoxin‑free.

Key Benefits

• Extended half‑life – DES reduces IGFBP‑3 binding, giving a ~24‑hour activity window.
• High purity – ≥ 99 % purity confirmed by HPLC, endotoxin‑free.
• Versatile applications – suitable for in‑vitro cell culture, animal models and ex‑vivo tissue studies.

Technical Specifications

Specification	Detail
Peptide	IGF‑DES – 2 mg per vial
Purity	≥ 99 % (HPLC)
Form	Lyophilized powder, amber glass vial (1 mL reconstitution volume)
Storage	–20 °C, desiccated; protect from light & moisture
Shelf‑life	24 months when stored as recommended
SKU	PL‑IGF‑DES‑2‑MG
GTIN / UPC	019876543219
Manufacturer	PrymaLab

Reconstitution & Recommended Use

1. Reconstitute the vial with **1 mL sterile bacteriostatic water** → final concentration **2 mg / mL** (2000 µg / mL). This yields the IGF‑DES 2 mg Long‑Acting Growth Factor Peptide ready for use.
2. In‑vitro dose: **20‑200 µg/mL** added to culture medium (adjust per assay).
3. In‑vivo rodent dose: **0.5‑2 mg/kg** sub‑cutaneously, once daily or every other day.
4. Maximum single dose: **10 mg** per animal per day.

Safety Disclaimer

This product is supplied for **personal, non‑clinical research use only**. It is **not a medication** and does **not** diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.